Pediatric RISE: Development of a Poverty‐Targeted Cash Support Intervention for Pediatric Cancer
RISE was acceptable and valuable, with appropriate mitigation of the risk of means-tested government benefit loss or reduction by intervention design. Parent feedback informed refinement, including an increase in cash disbursement dollar amount and duration. The refined RISE intervention is currently being evaluated in a multi-site, randomized signal-finding study.
Authors
- Colleen Kelly (ORCID: https://orcid.org/0009-0001-6577-714X)
- Rahela Aziz‐Bose (ORCID: https://orcid.org/0000-0003-4753-5144)
- Jane Kellett (ORCID: https://orcid.org/0000-0003-0586-3203)
- Puja J. Umaretiya (ORCID: https://orcid.org/0000-0002-7587-4875)
- Sunyu Kang (ORCID: https://orcid.org/0000-0002-8606-2979)
- Leanne Duhaney
- Anna Revette (ORCID: https://orcid.org/0000-0002-4590-755X)
- Erika N. Hanson (ORCID: https://orcid.org/0000-0002-5952-0962)
- Kira O'Neil Bona (ORCID: https://orcid.org/0000-0001-5602-7059)
- Paul Morgan (ORCID: https://orcid.org/0000-0003-1439-9545)
- Amy J. Lin (ORCID: https://orcid.org/0009-0008-2876-501X)
Institutions
- Boston Children's Hospital (US)
- Harvard University (US)
- Harvard University Press (US)
- Dana-Farber Cancer Institute (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1002/pbc.32103
- Primary Topic
- Childhood Cancer Survivors' Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00